Texas doesn't stop. Bristol Myers Squibb (BMS) — a Fortune 100 pharma giant — is reportedly eyeing Houston for a $1B, 600,000-sq-ft manufacturing super-base. Per leaked filings to Texas's JETI program, the project (codename "Project Argonaut") has applied for a 10-year school-property-tax abatement; if finalized, the $1B would deploy 2027–2029. The site: Generation Park, ~20 miles northeast of downtown. Officials call 600K sq ft "a starting point, not a ceiling."
BMS says it will recruit heavily from Texas-based senior professionals, technical graduates, and community-college talent.
Not yet 100% confirmed — BMS lists 16 candidate cities across the central/eastern U.S. in final contention.
The 10-year school-property-tax abatement via JETI plus no state income tax make Texas the magnet. 16 cities competed; Houston's medical + biotech depth is a real edge.
BMS plans to pour $40B into U.S. R&D + domestic manufacturing over five years. Houston winning this $1B slice would anchor it as a long-term-pharma commercial base.
The chosen site sits in Generation Park, ~20 mi NE of downtown — a fast-growing managed district. Reinforces Houston's pull for high-skill manufacturing.
A $1B pharma base + 489 six-figure jobs deepens Houston's high-income, high-skill consumer base — exactly the demand profile Cube-Age serves from its Houston hub. Pharma / lab build-outs also pull packaging, warehouse and equipment demand. Pair with IAH Houston airport (atlas-c62) and Frisco / McKinney income (atlas-c70) for the wider Texas growth picture.
Source: Texas JETI (Jobs, Energy, Technology & Innovation) program filings for "Project Argonaut"; reporting via Dealmoon Houston / Guide-Houston. Figures (investment, jobs, salary, timeline) per the official filing as reported; final site and schedule not yet confirmed by BMS.